Alcimed: Innovation and New Business Consulting

News

Discover Nautilus.ai, Alcimed's new business in digital and AI

Who is Alcimed?

Every day we help build the world of tomorrow

For over 30 years

Our team of 220 explorers has been supporting our clients across the world in their innovation and new market development projects.

Our exploration territories

"The benefit that really Alcimed brought to the table was to have an expert intermediary to take us through the process to really challenge our thinking."
Mark TWYMAN
Senior VP and Chief Commercial Officer
"The Alcimed team has allowed us to structure the project appropriately, to plan it in the best possible way, and to make sure that every single step of the project was successful."
Federico Bianco
Head of the Special Care Unit
"Together between Alcimed and Nestlé Health Science, we made informed decision on where the best opportunities were and why and how to select the most valuable assets in our investigation."
Bernard Cuenoud
Global Head of Research and Clinical Development

Strategic marketing

Clients & Patients

R&D

Commercial strategy

Innovation

New partners

Strategy

Healthcare

Environment & Climate

Beauty & Nutrition

Energy & mobility

Sovereignty

Tech & data

Healthcare

Virtual reality in healthcare: a new therapeutic tool?

What is virtual reality? The first volume of the Treatise on Virtual Reality, published in 2006, defines it as “a scientific and technical field using computing and interfaces in order to simulate ...
Healthcare

Evolution of pharmaceutical R&D: three key trends to follow

Trend 1: the use of new innovative trial designs The successes obtained during the pandemic offered the pharmaceutical industry a valuable glimpse of how innovative trial designs can disrupt ...
Healthcare

Microbiome therapeutics: what are the current advances?

Due to the current challenges in modern treatment of disease, there is mounting evidence to suggest the potential of microbiome therapeutics.
Data - AI

The Road to AI Adoption in Medical Imaging: Deployment Pathways & Hurdles

AI Deployment in Medical Imaging: Development Pathways So far, a prominent mechanism for AI deployment into clinics has been via medical imaging companies developing first-party algorithms that are ...
Cross-sector

Accelerating R&D Pipeline With LLMS And Generative AI In Pharma: Opportunities & Common Pitfalls

5 Opportunities for LLMS and Generative AI in Pharma R&D Opportunity n°1: Increasing Efficiency in Drug Discovery As recent partnerships have shown (e.g., Isomorphic Labs with Novartis and ...